Dermatology
Latest News
Study points to need to improve identification of culprit in SJS/TEN cases
A single culprit drug was labeled in 17 cases, but physicians communicated certainty in only 7 of those cases.
Photo Rounds
Fade haircut or something else?
Latest News
Imaging techniques will revolutionize cancer detection, expert predicts
Jennifer Barton, PhD, and her colleagues are developing an OCT/fluorescence imaging falloposcope that is 0.8 mm in diameter, flexible, and...
News from the FDA/CDC
FDA approves ritlecitinib for ages 12 and up for alopecia areata
It is the second JAK inhibitor approved for treating alopecia areata, following approval of baricitinib (Olumiant) in June 2022 for alopecia...
Latest News
Study supports new NCCN classification for cutaneous squamous cell carcinoma
The high- and very-high-risk groups in the NCCN guidelines identify SCCs at greatest risk for developing poor outcomes.
Latest News
FDA passes on olorofim despite critical need for antifungals
There are only four antifungal classes currently available, and there are few new candidates in the pipeline.
Latest News
Warts difficult to eradicate in immunocompromised children
Warts completely resolved with treatment in only 24% of children undergoing active cancer treatment.
Latest News
Prognostic factors of SCCs in organ transplant recipients worse compared with general population
SCCs developed most frequently on the head/neck in organ transplant recipients and on the arms/hands in the general population.
Opinion
A 63-year-old male presented for evaluation of worsening genital lesions and associated swelling
Shave biopsy of the penile shaft demonstrated dermal interstitial edema with dilated thin-walled vessels and overlying acanthosis.
Feature
FDA warns of tattoo ink tied to dangerous infections
“I’ve seen several different infections from tattooing, and they are from organisms that tend to contaminate things in damp, liquid-type...
Feature
After Yusimry’s steep discount, little clarity on future adalimumab biosimilar pricing
SmithRx, which bills itself as “next-generation pharmacy benefits management,” announced that it will offer Yusimry to its members at a discount...